Zusammenfassung
Das Melanom ist der maligne Tumor der Melanozyten (Pigmentzellen) der Haut und der körpernahen Schleimhäute, in Ausnahmefällen auch anderer Organe (Auge, Meningen, Lymphknoten, etc.)
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
Literatur
Mackie RM,Young D (1984) Human malignant melanoma. IntJ Dermatol 23: 433
Kopf AW Kripke ML, Stern RS (1984) Sun and malignant melanoma.J Am Acad Dermatol 11: 674
Reimer RR, Wallace HC Jr, Greene MH, et al (1978) Precursor lesions in familial melanoma. JAMA 239: 744
Kaplan EN (1974)The risk of malignancy in large congenital naevi. Plast Reconstr Surg 53:421
Elder DE, Goldman LI, Goldman SC, et al (1980) The dysplastic naevus syndrome: a phenotypic association of melanoma. Cancer 46: 1787
Lynch HT, Fusaro RM, Peter J, et al (1981)Tumourspectrum in the FAMMM syndrome. Br J Cancer 44: 553
Gromet MA, Epstein WL, Blois MS (1979)The regressing thin malignant melanoma—a distinctive lesion with metastatic potential. Cancer 42: 2282
Lerman RI, Murray D, O’Hara JM, et al (1970) Malignant melanoma of childhood: a clinicopathologic study and a report of 12 cases. Cancer 25: 436
Rampen FHJ, Van der Esch EP (1985) Biopsy and survival of malignant melanoma. J Am Acad Dermatol 12: 385
Friedman RJ, Rigel DS, Kopf AW (1985) Early detection of malignant melanoma. The role of physician examination and self examination of the skin. Cancer 35: 4
Clark WH Jr, From L, Bernadino EA, et al (1969) The histogenesis and biologic behaviour of primary human malignant melanoma of the skin. Cancer Res 29: 705
Breslow A (1970) Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma. Ann Surg 172: 902
Garbe C, Stadler R, Orfanos CE (1986) Prognose-orientierte Therapie bei malignem Melanom. Hautarzt 37: 365
Balch CM (1980) Surgical management of regional lymph nodes in cutaneous melanoma.) Am Acad Dermatol 3: 511
Martijn H, Oldhoff J, Oosterhuis JW, et al (1983) Indications for elective groin dissection in clinical stage I patients with malignant melanoma of the lower extremity treated by hyperthermic regional perfusion. Cancer 52: 1526
Sim FH,Taylor WF, Ivins JC, et al (1978)A prospective randomized study of the efficacy of routine elective lymphadenectomy in management of malignant melanoma. Cancer 41: 948
Veronesi U, Adamus J, Bandiera CC, et al (1972) Inefficacy of immediate node dissection in stage I melanoma of the limbs. N Engl J Med 197: 627
Balch CM, Soong SJ, Milton GW, et al (1982) A comparison of prognostic factors and surgical results in 1786 patients with localized (stage I) melanoma treated in Alabama, USA, and New South Wales, Australia. Ann Surg 196: 677
McCarthy WH, Shaw HM, Milton GW (1985) Efficacy of selective lymph node dissection in 2347 patients with clinical stage I malignant melanoma. Surg Gynecol Ob-stet 161: 575
Munz DL, Altmeyer P, Holzmann H, et al (1982) Der Stellenwert der Lymphszintigraphie in der Behandlung maligner Melanome. Dtsch Med Wochenschr 107: 86
Veronesi MD, Adamus J, Aubert C, et al (1982)A randomized trial of adjuvant chemotherapy and immunotherapy in cutaneous melanoma. N Engl J Med 307: 913
Gutterman JU, McBride C, Fredrick EJ, et al (1973) Active immunotherapy with BCG for recurrent malignant melanoma. Lancet i: 1208
Terry WD (1980) Immunotherapy of malignant melanoma. N Engl J Med 303: 1174
Silber HKB, Salinas FA, Kong S (1986) Interferons in cancer treatment. MES Medical Education Services, Toronto
Foon KA, Sherwin SA, Abrams PG, et al (1985) A phase I trial of recombinant gamma interferon in patients with cancer. Cancer Immunol Immunother 20: 193
Creagan ET, Ahmann DL, Frytak S, et al (1987)Three consecutive phase-II-studies of recombinant interferon alpha-2a in advanced malignant melanoma. Cancer 59:638
Ettinghausen SE, Rosenberg SA (1986)The adoptive immunotherapy of cancer using lymphokine activated killer cells and recombinant interleukin 2. Springer Semin Immunopathol 9: 51
Balch CM, Milton GW, Shaw HM, et al (1985) Cutaneous melanoma, clinical management and treatment results worldwide. Lippincott, Philadelphia
Bellet RE, Mastrangelo MJ, et al (1979) Chemotherapy of metastatic melanoma. In: Clark WH (ed) Human malignant melanoma. Crune & Stratton, New York, p 325
Voigt H, Caselitz J,Jänner M (1981)Veno-occlusives Syndrom mit akuter Leberdystrophie unter Dacarbazin-Therapie eines malignen Melanoms. Klin Wochenschr 69: 229
Overgaard J (1986) The role of radiotherapy in recurrent and metastatic malignant melanoma: a clinical radiobiological study. Int J Radiat Oncol Biol Phys 12: 867
Rigel DS, Kopf AW, Friedman RJ (1987) The rate malignant melanoma in the United States: are we making an impact? J Am Acad Dermatol 17: 1050
Rights and permissions
Copyright information
© 1990 Springer-Verlag/Wien
About this paper
Cite this paper
Fritsch, P., Pichler, E. (1990). Klinik, Differentialdiagnose und Therapie des Melanoms. In: Prostatakarzinom Malignes Melanom Bildgebende Verfahren in der Onkologie. Angewandte Onkologie. Springer, Vienna. https://doi.org/10.1007/978-3-7091-9107-1_2
Download citation
DOI: https://doi.org/10.1007/978-3-7091-9107-1_2
Publisher Name: Springer, Vienna
Print ISBN: 978-3-211-82228-9
Online ISBN: 978-3-7091-9107-1
eBook Packages: Springer Book Archive